Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

PAHC - Phibro Animal Health Corp. - Ordinary Shares - Class A


IEX Last Trade
21.07
-0.400   -1.898%

Share volume: 286,970
Last Updated: Fri 30 Aug 2024 09:59:56 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$21.47
-0.40
-1.86%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
53%
Profitability 23%
Dept financing 47%
Liquidity 74%
Performance 80%
Company vs Stock growth
vs
Performance
5 Days
0.29%
1 Month
14.32%
3 Months
18.81%
6 Months
66.98%
1 Year
51.06%
2 Year
49.76%
Key data
Stock price
$21.07
P/E Ratio 
176.78
DAY RANGE
N/A - N/A
EPS 
$0.06
52 WEEK RANGE
$8.96 - $22.31
52 WEEK CHANGE
$0.54
MARKET CAP 
427.089 M
YIELD 
2.24%
SHARES OUTSTANDING 
20.338 M
DIVIDEND
$0.12
EX-DIVIDEND DATE
06/05/2024
NEXT EARNINGS DATE
11/06/2024
BETA 
0.96
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$287,080
AVERAGE 30 VOLUME 
$167,934
Company detail
CEO: Jack Bendheim
Region: US
Website: https://www.pahc.com/
Employees: 1,005
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

phibro animal health corporation is a leading global diversified animal health and mineral nutrition company. we are dedicated to helping meet the growing demand for animal protein. we concentrate exclusively on animals for food production and are one of the few global companies offering a comprehensive range of animal health and mineral nutrition products. for over 40 years we have been committed to providing livestock producers with value-based products and solutions to help them maintain and enhance the health of their animals. we develop, manufacture and market a broad range of products for food animals including poultry, swine, beef and dairy cattle and aquaculture. our products help prevent, control and treat diseases, enhance nutrition to help improve health and contribute to balanced mineral nutrition. phibro animal health corporation reported net sales of $764 million for the fiscal year ended june 30, 2017. our more than 1,400 employees are proud to manufacture and market our

Recent news